JPMORGAN CHASE & CO - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is and the CUSIP is 761330959. A total of 6 filers reported holding REVANCE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$180,079
+100.1%
15,700
+241.3%
0.00%
Q1 2022$90,0004,6000.00%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Sea Otter Advisors LLC 5,000$57,3500.03%
GROUP ONE TRADING, L.P. 334,400$3,835,5680.01%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
SIMPLEX TRADING, LLC 42,000$4810.00%
JPMORGAN CHASE & CO 15,700$180,0790.00%
JANE STREET GROUP, LLC 64,900$744,4030.00%
View complete list of REVANCE THERAPEUTICS INC shareholders